Clinical Trial Update: Oxaliplatin and Topotecan in Treating Patients With Previously Treated Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [Phase 1]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1 study evaluating oxaliplatin and topotecan in patients with previously treated ovarian epithelial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Eloxatin (oxaliplatin) (oxaliplatin)
• Hycamtin (Topotecan) (Topotecan)

Snippet

Sponsor: NYU Langone Health | Conditions: Fallopian Tube Cancer, Ovarian Cancer | Phase 1 | Status: COMPLETED